2022
DOI: 10.3389/fimmu.2021.798155
|View full text |Cite
|
Sign up to set email alerts
|

When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors

Abstract: Atherosclerosis (ATS), the change in structure and function of arteries with associated lesion formation and altered blood flow, is the leading cause of cardiovascular disease, the number one killer worldwide. Beyond dyslipidemia, chronic inflammation, together with aberrant phenotype and function of cells of both the innate and adaptive immune system, are now recognized as relevant contributors to atherosclerosis onset and progression. While the role of macrophages and T cells in atherosclerosis has been addr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 149 publications
1
23
0
Order By: Relevance
“…Dyslipidemia is a risk factor for many diseases, such as cardiovascular disease (CVD), metabolic syndrome, and obesity ( Palano et al, 2021 ; Alsayed et al, 2022 ; Subramanian, 2022 ). Dyslipidemia is mainly reflected by the abnormalities in low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TG), and total cholesterol (TC).…”
Section: Introductionmentioning
confidence: 99%
“…Dyslipidemia is a risk factor for many diseases, such as cardiovascular disease (CVD), metabolic syndrome, and obesity ( Palano et al, 2021 ; Alsayed et al, 2022 ; Subramanian, 2022 ). Dyslipidemia is mainly reflected by the abnormalities in low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TG), and total cholesterol (TC).…”
Section: Introductionmentioning
confidence: 99%
“…Atherosclerosis is an inflammatory chronic vascular disease primarily associated with oxidative stress and endothelial dysfunction that leads to manufacturing CVD [ 23 , 24 ]. Numerous studies confirm that hyperlipidaemia alone is not sufficient for atherosclerosis development; rather, inflammation becomes an additional stimulus [ 25 ].…”
Section: Atherosclerosis: Risk Factors and The Mechanism Of Developmentmentioning
confidence: 99%
“…NK cells are bone marrow derived lymphocytes not passing the thymus and thus they lack the T lymphocyte marker CD3 + (CD3 -CD56 + ). As a part of the innate immune response, they are known for the surveillance of viruses and tumour growth, but less is known about NK cell responses in atherosclerotic disease (83). Murine studies show that NK cell activation is mediated either through macrophage/dendritic cell interaction, or through the direct stimulus from IL-15, IL-12 or IL-18, causing a hyperactivated state that is considered pro-atherogenic, and it has been proposed that NK cell contribution to the atherogenic process involves cytotoxic factors and cytokine secretion (84)(85)(86)(87).…”
Section: Natural Killer Cellsmentioning
confidence: 99%
“…There has been contrasting evidence of NK cell function in plaque progression, with NK cells displaying in part antiinflammatory cytokines (like IL-10, IL-4, and IL-13) and on the other hand proinflammatory cytokines like IFN-γ (88). One explanation for the non-uniform reports on NK cell participation in atherosclerosis, might be that different murine models have been used in different studies (83). Another complexity is the various not yet fully characterised NK cell sub lineages that might play different and sometimes contrasting roles in atherosclerotic disease pathogenesis (79).…”
Section: Natural Killer Cellsmentioning
confidence: 99%